More articles from Reviews

Non-COVID-19 respiratory viral infection
Cláudio Nunes-Silva, Ana Teresa Vilares, Valentijn Schweitzer, Susana Castanhinha, António Martins, Maria João Lopes, Tommaso Ascoli-Bartoli, Gabriela Canelas, Holly R. Keir, Flávia Cunha, André Silva-Pinto, Sandra Rebelo, Rui Guimarães Cunha, Margarida Tavares

Breathe Mar 2022, 18 (1) 210151; DOI: 10.1183/20734735.0151-2021
Pulmonologists’ work and clinical life during the COVID-19 pandemic: a society-led survey
Pia Iben Pietersen, Lars Konge, Rasmus Jørgensen, Daiana Stolz, Amy Farr, Christian B. Laursen

Breathe Mar 2022, 18 (1) 220001; DOI: 10.1183/20734735.0001-2022
How COVID-19 interacts with interstitial lung disease
Katherine J. Myall, Jennifer L. Martinovic, Alex West

Breathe Mar 2022, 18 (1) 210158; DOI: 10.1183/20734735.0158-2021
New developments in tuberculosis diagnosis and treatment
Cara M. Gill, Lorraine Dolan, Laura M. Piggott, Anne Marie McLaughlin

Breathe Mar 2022, 18 (1) 210149; DOI: 10.1183/20734735.0149-2021
A pragmatic guide to choosing biologic therapies in severe asthma
Joanne E. Kavanagh, Andrew P. Hearn, David J. Jackson

Breathe Dec 2021, 17 (4) 210144; DOI: 10.1183/20734735.0144-2021
The use of treatable traits to address COPD complexity and heterogeneity and to inform the care
Katarzyna Duszyk, Rebecca F. McLoughlin, Peter G. Gibson, Vanessa M. McDonald

Breathe Dec 2021, 17 (4) 210118; DOI: 10.1183/20734735.0118-2021
Stating the obvious: intravenous magnesium sulphate should be the first parenteral bronchodilator in paediatric asthma exacerbations unresponsive to first-line therapy
Gokul Erumbala, Sabu Anzar, Amjad Tonbari, Ramadan Salem, Colin Powell

Breathe Dec 2021, 17 (4) 210113; DOI: 10.1183/20734735.0113-2021
Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy
Daniel H. Tewkesbury, Rebecca C. Robey, Peter J. Barry

Breathe Dec 2021, 17 (4) 210112; DOI: 10.1183/20734735.0112-2021
Precision medicine in bronchiectasis
Thomas Pembridge, James D. Chalmers

Breathe Dec 2021, 17 (4) 210119; DOI: 10.1183/20734735.0119-2021
Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)
Aditi Sinha, Kevin W. Southern

Breathe Sep 2021, 17 (3) 210088; DOI: 10.1183/20734735.0088-2021

Main menu

User menu

Search

More articles from Reviews

Pages

Contact us